Series BAIUnited States · San FranciscoJun 03, 2026

Collate raises $95.0M Series B (United States, Jun 2026)

$95.0M
$95 million
Browse investors in United States →
Generated social card
Collate social card
Headline

AI Startup Collate Raises $95 Million To Automate Life Sciences Paperwork - Forbes

About

Collate is an AI startup that develops tools to automate paperwork in the life sciences sector. The company targets pharmaceutical companies, medical device manufacturers, and biotech firms, aiming to streamline regulatory filings and clinical trials. With a recent funding round of $95 million, Collate is positioned to capitalize on the growing demand for AI solutions in life sciences documentation.

Article summary

AI Startup Collate Raises $95 Million To Automate Life Sciences Paperwork  Forbes

Founder
Surbhi Sarna
Co-founder
Investors · 1
Redpoint VenturesLead
FUND
Related rounds
Jul 13, 2026Guthrie AI$4.0M—United States
Jul 13, 2026Together AI$800.0MSeries CUnited States
Jul 12, 2026Physical Intelligence$1.00B—United States
Jul 12, 2026Periodic Labs$300.0MSeedUnited States